article = {COR-2022-4-103}
title = {Review Article on Epithelial Ovarian Cancer with Peritoneal Metastasis}
journal = {Clinical Oncology and Research}
year = {2022}
issn = {2613-4942}
doi = {http://dx.doi.org/10.31487/j.COR.2022.04.03}
url = {https://www.sciencerepository.org/review-article-on-epithelial_COR-2022-4-103 
author = {K. Grammatikakis,E. Halkia,K.  Patsouras,}
keywords = {Ovarian, cancer, chemotherapy, intraperitoneal chemotherapy, upfront surgery, visceral segmental serosectomy (VSS), peritoneal cancer index (PCI), small bowel, carcinomatosis, cytoreductive surgery, ovarian cancer, CA125, screening, debulking, immunotherapy, residual tumor, malignant ascites}
abstract ={Introduction: Many advances have emerged in the management of peritoneal metastases of ovarian cancer origin, widely known as the most common gynaecological malignancy. This review is an update of the current management algorithm of peritoneal carcinomatosis of ovarian cancer, including screening methods, biomarkers and surgical techniques, in an effort to shed some light into this difficult to treat malignancy.
Objective: To assess awareness in the management of epithelial ovarian cancer (EOC) with peritoneal metastasis with updated therapeutic standpoints.}